SEStefan Ehlers

Stefan Ehlers

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Stefan Ehlers has a total of 58 co-authors. Here are the top co-authors by number of shared publications:

  • Norbert Reiling

    Research Center Borstel/Leibniz Lung Center, RG Microbial Interface Biology, German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Borstel, Germany

    3 shared publications
  • Boris A. Dmitriev

    N.F. Gamaleya Institute for Epidemiology and Microbiology, Moscow, Russia

    2 shared publications
  • Ernst T. Rietschel

    N. F. Gamaleya Institute for Epidemiology and Microbiology, Moscow 123098,1 N. D. Zelinsky Institute of Organic Chemistry, Moscow 119991, Russia,2 Department of Immunochemistry and Biochemical Microbiology, Research Center Borstel, Center for Medicine and Biosciences, D-23845 Borstel, Germany3

    2 shared publications
  • Filip V. Toukach

    N. F. Gamaleya Institute for Epidemiology and Microbiology,1 N. D. Zelinsky Institute of Organic Chemistry, Moscow, Russia,3 Department of Immunochemistry and Biochemical Microbiology, Research Center Borstel, Leibniz Center for Medicine and Biosciences, Borstel, Germany2

    2 shared publications
  • Jochen Benini

    Division of Molecular Infection Biology, Research Center Borstel , Borstel

    2 shared publications
  • Klaus Pfeffer

    Institute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany

    2 shared publications

Latest Publications

  • Open Access

    The Granuloma in Tuberculosis: Dynamics of a Host–Pathogen Collusion

    by Stefan Ehlers, Ulrich E. Schaible

    A granuloma is defined as an inflammatory mononuclear cell infiltrate that, while capable of limiting growth of Mycobacterium tuberculosis, also provides a survival niche from which the bacteria may disseminate. The tuberculosis lesion is highly dynamic and shaped by both, immune response elements and the pathogen. In the granuloma, M. tuberculosis switches to a non-replicating but energy-generating life style whose detailed molecular characterization can identify novel targets for chemotherapy. To secure transmission to a new host, M. tuberculosis has evolved to drive T cell immunity to the point that necrotizing granulomas leak into bronchial cavities to facilitate expectoration of bacilli. From an evolutionary perspective it is therefore questionable whether vaccination and immunity enhancing strategies that merely mimic the natural immune response directed against M. tuberculosis infection can overcome pulmonary tuberculosis in the adult population. Juxtaposition of molecular pathology and immunology with microbial physiology and the use of novel imaging approaches afford an integrative view of the granuloma’s contribution to the life cycle of M. tuberculosis. This review revisits the different input of innate and adaptive immunity in granuloma biogenesis, with a focus on the co-evolutionary forces that redirect immune responses also to the benefit of the pathogen, i.e., its survival, propagation, and transmission.


  • Open Access

    99th Dahlem Conference on Infection, Inflammation and Chronic Inflammatory Disorders: Lifestyle changes affecting the host–environment interface

    by S. Ehlers, S H E Kaufmann

    Summary: In industrialized nations and high-income regions of the world, the decline of infectious diseases is paralleled by an increase in allergic, autoimmune and chronic inflammatory diseases (AACID). Changes in lifestyle in westernized societies, which impact individually and collectively on intestinal microbiota, may – at least in part – account for the AACID pandemic. Many disease genes that contribute to AACID encode pattern recognition and signalling molecules in barrier-associated cells. Interactions between gene products and environmental factors depend highly upon the host's state of maturation, the composition of the skin and gut microflora, and exposure to pollutants, antibiotics and nutrients. Inflammatory stress responses, if regulated appropriately, ensure immunity, health and relative longevity; when they are dysregulated, they can no longer be terminated appropriately and thus precipitate AACID. The 99th Dahlem Conference brought together experts of various disciplines (genetics, evolution biology, molecular biology, structural biology, cell biology, immunology, microbiology, nutrition science, epidemiology and clinical medicine) to discuss the multi-faceted relationships between infection, immunity and inflammation in barrier organs and the development of AACID. In Clinical and Experimental Immunology we are presenting a compilation of background papers that formed the basis of discussions. Controversial viewpoints and gaps in current knowledge were examined and new concepts for prevention and treatment of CID were formulated.


  • Fucosyltransferase IV and VII-directed selectin ligand function determines long-term survival in experimental tuberculosis

    by Stefan Ehlers, Tanja Schreiber, Annette Dunzendorfer, John B. Lowe, Christoph Hölscher


  • Lazy, Dynamic or Minimally Recrudescent? On the Elusive Nature and Location of the Mycobacterium Responsible for Latent Tuberculosis

    by S. Ehlers

    In the absence of symptoms characteristic of tuberculosis (TB), a condition termed clinical latency, diagnosis is currently impossible by detection of the microorganism itself and resorts to the demonstration of an immunological memory response to antigens of Mycobacterium tuberculosis (Mtb). Whether latency is synonymous to chronic persistent infection with viable Mtb in all instances has been difficult to establish. The physical and physiological state of Mtb during latency is much disputed: are organisms mostly dormant, in a nonreplicating state of persistence, and characterized by lipid inclusions and metabolic adaptation to hypoxia, or do they continue to replicate and sometimes even escape from the fringes of granulomatous lesions or alveolar epithelial cells into adjacent airways, thereby inducing recurring immune responses? The physical nature of Mtb during latency is important as it determines which antimicrobial agents may be used to kill it, which immunomodulating strategies (including post-exposure vaccines) may be appropriate to contain it, and which diagnostic measures may be most useful to discriminate latent from reactivating infection. Two major viewpoints exist: one argues that Mtb persists mostly in a lazy state within granulomatous lesions, but periodically recrudesces, and that there is considerable heterogeneity for different sites within the lesion and within the infected lung. Throughout latency, there is a dynamic immunological interplay between Mtb and the host, necessitating continuous recruitment of cells into the granuloma, and reactivation occurs when this dynamic cellular exchange becomes dysregulated. Another view holds that dormant Mtb reside within alveolar epithelial cells in the lung apices and in adipocytes, with reactivation being associated with the upregulation of resuscitation promoting factors within Mtb and the escape of newly dividing microorganisms into alveoli and bronchi in the form of lipid pneumonia. These views need not be mutually exclusive. However, if minimal intermittent recrudescence were to take place within the alveolar space, this would contradict the very definition of latency, which implies that no access of Mtb to the airways exists during latency.


  • Open Access

    Mycobacteria‐induced granuloma necrosis depends on IRF‐1

    by Sahar Aly, Jörg Mages, Norbert Reiling, Ulrich Kalinke, Thomas Decker, Roland Lang, Stefan Ehlers

    In a mouse model of mycobacteria‐induced immunopathology, wild‐type C57BL/6 (WT), IL‐18‐knockout (KO) and IFN‐αβ receptor‐KO mice developed circumscript, centrally necrotizing granulomatous lesions in response to aerosol infection with M. avium, whereas mice deficient in the IFN‐γ receptor, STAT‐1 or IRF‐1 did not exhibit granuloma necrosis. Comparative, microarray‐based gene expression analysis in the lungs of infected WT and IRF‐1‐KO mice identified a set of genes whose differential regulation was closely associated with granuloma necrosis, among them cathepsin K, cystatin F and matrix metalloprotease 10. Further microarray‐based comparison of gene expression in the lungs of infected WT, IFN‐γ‐KO and IRF‐1‐KO mice revealed four distinct clusters of genes with variable dependence on the presence of IFN‐γ, IRF‐1 or both. In particular, IRF‐1 appeared to be directly involved in the differentiation of a type I immune response to mycobacterial infection. In summary, IRF‐1, rather than being a mere transcription factor downstream of IFN‐γ, may be a master regulator of mycobacteria‐induced immunopathology.


  • Interferon‐gamma‐dependent mechanisms of mycobacteria‐induced pulmonary immunopathology: the role of angiostasis and CXCR3‐targeted chemokines for granuloma necrosis

    by S Aly, T Laskay, J Mages, A Malzan, R Lang, S Ehlers

    The mechanisms leading to granuloma caseation, a hallmark of tuberculosis (TB) in humans, are poorly understood. Lung histopathology of C57BL/6 (WT) mice 16 weeks after aerosol infection with Mycobacterium avium strain TMC724 is uniquely characterized by centrally necrotizing granulomas, strongly resembling human TB lesions. However, IFN‐γ‐deficient (GKO) and IFN‐γ‐receptor‐deficient (GRKO) mice did not develop granuloma necrosis following M. avium infection. Comparison of differentially expressed genes in infected WT and GKO lungs by DNA microarray and RNase protection assays revealed that the angiostatic chemokines CXCL9–11 were significantly reduced in GKO mice. In contrast, angiogenic mediators such as angiopoietin and vascular endothelial growth factor, and angiogenic chemokines such as CXCL2, CCL3, and CCL4, remained unchanged or were expressed at higher levels than in infected WT mice, suggesting impaired neovascularization of the granuloma as a possible mechanism for caseation in WT mice. Granuloma vascularization was significantly decreased in central, but not peripheral, areas of granulomas of infected WT compared to GKO mice. In contrast to GRKO mice, WT mice showed signs of severe hypoxia in cells immediately surrounding the necrotic core of granulomas as measured immunohistochemically with a reagent detecting pimonidazole adducts. To test the hypothesis that CXCR3, the common receptor for the angiostatic chemokines CXCL9–11, is involved in granuloma caseation, histomorphology was assessed in M. avium‐infected mice deficient for CXCR3 (CXCR3‐KO). 16 weeks after infection, these mice developed caseating granulomas similar to WT mice. We conclude that IFN‐γ causes a dysbalance between angiostatic and angiogenic mediators and a concomitant reduction in granuloma vascularization, but that CXCR3‐targeted chemokines are not sufficient to induce granuloma necrosis in a mouse model of mycobacteria‐induced immunopathology. Copyright © 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.